By Molly Stech*
*The blog post below and the law review article it links to are the individual thoughts and views of the author and should not be attributed to any entity with which she is currently or has been affiliated. Read more
By Molly Stech*
*The blog post below and the law review article it links to are the individual thoughts and views of the author and should not be attributed to any entity with which she is currently or has been affiliated. Read more
Warmest greetings for this holiday season. While 2021 has continued to be challenging, we are thankful that our community has stayed strong and thrived, nonetheless. We hope that if the pandemic has directly affected you or your loved ones, you are finding your way back to peace and health. Read more
Now that fall has officially begun, C-IP2 is wrapping up the summer with our Fall Progress Report for 2021 covering activities June through August. This is also our first progress report under our new name, since we rebranded on July 1 as the Center for Intellectual Property x Innovation Policy (C-IP2, also: C-IP2), formerly the Center for the Protection of Intellectual Property (CPIP). Read more
C-IP2’s original post on the UC Hastings’ Evergreen Drug Patent Search Database can be read here.
Robin Feldman
Arthur J. Goldberg Distinguished Professor of Law
Albert Abramson ’54 Distinguished Professor of Law Chair
Director of the Center for Innovation at University of California Hastings
We would like to thank the author of the blog post for taking the time to look at our work for the Evergreen Drug Patent Database. Read more
By Kathleen Wills, Esq.*
Kathleen Wills is a graduate of Antonin Scalia Law School and former C-IP2 RA.
Artificial Intelligence and Big Data
While many of us have come to rely on biometrics data when we open our phones with Apple’s “Face ID,” speak to Amazon’s Alexa, or scan our fingerprints to access something, it’s important to understand some of the legal implications about the big data feeding artificial intelligence (AI) algorithms. Read more
The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at C-IP2.
The COVID-19 pandemic has shined a spotlight on the role of intellectual property in modern medicine and on the complex social questions surrounding a system that grants exclusive rights over life-or-death products. Read more
We are cautiously optimistic as locations around the globe move towards greater control of the COVID pandemic. With luck, diligence, and generosity by public and private sectors around the world, we can all strive for vaccines to be more widely accessible and a future in which we can see other in person again. Read more
The United States and other wealthy nations have access to plenty of COVID-19 vaccine doses and thus are beginning to get the pandemic under control, while less affluent countries do not have access to adequate doses and are still struggling with rising cases. Read more
The following post comes from Ryan Reynolds, a 3L at Scalia Law and Research Assistant at CPIP.
By Ryan Reynolds
The phrase “creators have rights, but no remedies” is likely familiar to those aware of the current landscape of copyright protection for individual creators and small businesses (“Creators”). Read more
The following post comes from Ryan Reynolds, a 3L at Scalia Law and Research Assistant at CPIP.
By Ryan Reynolds
In the 89 years following the publishing of the first Restatement of Law in 1932, the American Law Institute’s (ALI) Restatements have become an important tool for those in the legal community to better understand different bodies of law. Read more